Xilio Therapeutics Inc (XLO)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Assets | 139.17M | 111.51M | 92.36M | 77.84M | 60.93M | 82.61M | 89.87M | 74.66M |
Total Current Assets | 124.5M | 96.98M | 78.43M | 64.48M | 48.13M | 69.19M | 78.01M | 63.31M |
Cash and Equivalents | 120.39M | 93.27M | 75.38M | 59.77M | 44.7M | 33.98M | 74.95M | 61.26M |
Total Non-Current Assets | 21.71M | 21.78M | 20.73M | 19.73M | 18.61M | 18.97M | 17M | 16.19M |
Total Liabilities | 33.52M | 26.71M | 24.98M | 25.34M | 24.1M | 56.84M | 56.46M | 53.68M |
Total Current Liabilities | 21.12M | 16.19M | 16.29M | 16.93M | 15.96M | 31.58M | 38.64M | 38.02M |
Total Non-Current Liabilities | 15.61M | 12.07M | 8.69M | 8.42M | 8.14M | 25.26M | 17.82M | 15.66M |
Common Equity | 3k | 3k | 3k | 3k | 3k | 3k | 4k | 4k |
Retained Earnings | -249.11M | -271.75M | -291.11M | -307.86M | -325.51M | -342.72M | -356.64M | -370.66M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 62.72M | 36.32M | 218.06M | 139.17M | 60.93M |
Total Current Assets | 51.1M | 20.59M | 202.52M | 124.5M | 48.13M |
Cash and Equivalents | 48.85M | 19.24M | 198.05M | 120.39M | 44.7M |
Total Non-Current Assets | -29.52M | -83.29M | 185.43M | 105.65M | 36.83M |
Total Liabilities | 24.21M | 41.6M | 32.63M | 33.52M | 24.1M |
Total Current Liabilities | 5.21M | 22.16M | 12.78M | 21.12M | 15.96M |
Total Non-Current Liabilities | 28.62M | 27.05M | 29.6M | 15.61M | 8.14M |
Total Equity | -29.52M | -83.29M | 185.43M | 105.65M | 36.83M |
Common Equity | 0 | 1,000 | 3k | 3k | 3k |
Retained Earnings | -29.87M | -85.09M | -160.89M | -249.11M | -325.51M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.